CVS Health Corp (CVS)vsTalen Energy Corporation (TLN)
CVS
CVS Health Corp
$95.93
+1.17%
HEALTHCARE · Cap: $128.46B
TLN
Talen Energy Corporation
$364.74
-3.53%
UTILITIES · Cap: $16.39B
Smart Verdict
WallStSmart Research — data-driven comparison
CVS Health Corp generates 12435% more annual revenue ($405.62B vs $3.24B). CVS leads profitability with a 0.7% profit margin vs -0.7%. CVS earns a higher WallStSmart Score of 65/100 (C+).
CVS
Buy65
out of 100
Grade: C+
TLN
Hold48
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+45.3%
Fair Value
$140.72
Current Price
$95.93
$44.79 discount
Intrinsic value data unavailable for TLN.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Earnings expanding 63.1% YoY
Large-cap with strong market position
Reasonable price relative to book value
Generating 3.4B in free cash flow
Revenue surging 96.7% year-over-year
Earnings expanding 34.5% YoY
Areas to Watch
ROE of 3.8% — below average capital efficiency
0.7% margin — thin
Operating margin of 4.1%
Elevated debt levels
Trading at 15.4x book value
Weak financial health signals
ROE of -2.0% — below average capital efficiency
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : CVS
The strongest argument for CVS centers on PEG Ratio, EPS Growth, Market Cap. PEG of 0.28 suggests the stock is reasonably priced for its growth.
Bull Case : TLN
The strongest argument for TLN centers on Revenue Growth, EPS Growth. Revenue growth of 96.7% demonstrates continued momentum.
Bear Case : CVS
The primary concerns for CVS are Return on Equity, Profit Margin, Operating Margin. A P/E of 44.2x leaves little room for execution misses. Thin 0.7% margins leave little buffer for downturns.
Bear Case : TLN
The primary concerns for TLN are Price/Book, Piotroski F-Score, Return on Equity. Debt-to-equity of 6.34 is elevated, increasing financial risk.
Key Dynamics to Monitor
CVS profiles as a value stock while TLN is a hypergrowth play — different risk/reward profiles.
TLN carries more volatility with a beta of 1.60 — expect wider price swings.
TLN is growing revenue faster at 96.7% — sustainability is the question.
CVS generates stronger free cash flow (3.4B), providing more financial flexibility.
Bottom Line
CVS scores higher overall (65/100 vs 48/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
CVS Health Corp
HEALTHCARE · HEALTHCARE PLANS · USA
CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.
Visit Website →Talen Energy Corporation
UTILITIES · UTILITIES - INDEPENDENT POWER PRODUCERS · USA
Talen Energy Corporation (Ticker: TLN) is a prominent power generation and infrastructure firm based in the United States, focused on delivering reliable and sustainable energy solutions through a diverse portfolio that encompasses both traditional and renewable sources. The company's strategic initiatives are aimed at addressing the increasing demand for electricity while enhancing environmental sustainability and grid resilience. With a commitment to innovation and technological advancement, Talen Energy is well-positioned to capitalize on the evolving energy landscape, making it an appealing investment opportunity for institutional investors seeking exposure to the transition toward cleaner energy alternatives.
Compare with Other HEALTHCARE PLANS Stocks
Want to dig deeper into these stocks?